Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline for glycemic control in adults with type 2 diabetes mellitus on metformin
IRCT20100314003565N9Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cabergoline in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Fast Blood Sugar, 2-hour post prandial glucose and 1 more. Started Mar 2018; status: completed.
02
Drugs
cabergoline
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20100314003565N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100314003565N9.